Kazan Federal University Digital Repository

Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

Files in this item

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account